Oil and Gas PSUs under the Ministry of Petroleum and Natural Gas, Government of India, acting as responsible corporate citizens, are extending their helping hand to support the nation in its efforts to combat the second wave of the COVID 19 pandemic. In this regard, they are specifically working to find transportation solutions for Liquid Oxygen.
Presently, there are 12 tankers and 20 ISO Containers with the capacity of 650 MT. The figure is going to improve substantively, with the numbers likely to go up to 26 tankers and 117 ISO containers by the end of this month, with the capacity of 2314 MT.95 ISO Containers are being purchased, with a capacity of 1940 Metric Tonne. Orders have already been placed for 30 ISO Containers, with the capacity of 650 MT while negotiations are underway for the remaining containers.
Orders have been placed for ten thousand cylinders of 40/ 50 litrecapacity and 300 cylinders of larger capacity (150 of 500 litre and 150 of 450 litre). Dispatch of these cylinders is likely to begin soon.
These companies are also importing Liquid Oxygen. 900 MT of Liquid Oxygen is being imported on Gratis basis from Bahrain, UAE, Saudi Arabia, Kuwait and Thailand. A part of the consignment has already been received while a portion of it will be received shortly. In addition, 12840 MT of Liquid Oxygen is being imported on commercial basis, taking total number of imports to 13740 MT.
6,738 Oxygen Concentrators, 3,856 Oxygen Cylinders, 16 Oxygen Generation Plants, 4,668 ventilators/ Bi PAP/ C PAP and more than 3L Remdesivir vials received as part of global aid to India have been delivered/ dispatched to States and UTs to augment and supplement their infrastructure, so far. The Union Government is ensuring that the global aid is being expeditiously delivered to States and UTs through fast custom clearances, and use of air and road.
In another significant development, the cumulative number of COVID-19 vaccine doses administered in the country has crossed the landmark of 17 Cr as the Phase-3 of the nationwide Vaccination Drive expands further.
India is the fastest country globally to administer 17 crore COVID vaccine doses. China took 119 days and USA took 115 days for reaching the same landmark.
A total of 17,01,76,603 vaccine doses have been administered through 24,70,799 sessions, as per the provisional report till 7 am today. These include 95,47,102 HCWs who have taken the 1st dose and 64,71,385 HCWs who have taken the 2nddose, 1,39,72,612 FLWs (1stdose), 77,55,283
FLWs (2nddose), 20,31,854 beneficiaries under 18-45 age group (1stdose), 5,51,79,217 (1stdose) and 65,61,851 (2nd dose) beneficiaries aged 45 to 60 years. 5,36,74,082 1stdose beneficiaries and 1,49,83,217 2nd dose beneficiaries of more than 60 years old.
Age Group 18-44 years
Age Group 45 to 60 years
Over 60 years
Ten states account for 66.79% of the cumulative doses given so far in the country.
2,46,269 beneficiaries of the age group 18-44 years received their first dose of COVID vaccine today and cumulatively 20,31,854 across 30 States/UTs during the last 24 hours. Table below shows the cumulative vaccine doses administered to 18-44 years age group till now.
A & N Islands
Jammu & Kashmir
More than 6.8 lakh vaccination doses were administered in the last 24 hours.
As on Day-114 of the vaccination drive (9th May, 2021), 6,89,652 vaccine doses were given. Across 5,685 sessions, 4,05,325 beneficiaries were vaccinated for 1st dose and 2,84,327 beneficiaries received their 2nd dose of vaccine.
Date: 9th May,2021 (Day-114)
45 to 60 years
Over 60 years
India’s cumulative recoveries stand at 1,86,71,222 today. The National Recovery Rate is 82.39%.
3,53,818 recoveries were registered in the last 24 hours.
Ten states account for 74.38% of the new recoveries.
Average daily recovery of more than 3.28 lakh cases has been recorded in last 10 days as shown below.
3,66,161 new cases were registered in the last 24 hours.
Ten States reported 73.91% of the new cases in last 24 hours.
Maharashtra has reported the highest daily new cases at 48,401. It is followed by Karnataka with 47,930 while Kerala reported 35,801 new cases.
India’s total Active Caseload has reached 37,45,237. It now comprises 16.53% of the country’s total Positive Cases. A net incline of 8,589cases recorded from the total active caseload in the last 24 hours.
13 States cumulatively account for 82.89% of India’s total Active Cases.
The National Mortality Rate has been falling and currently stands at 1.09%.
3,754 deaths were reported in the last 24 hours.
Ten States account for 72.86% of the new deaths. Maharashtra saw the maximum casualties (572). Karnataka follows with 490 daily deaths.
Three States/UTs have not reported any COVID-19 deaths in the last 24 hours. These are D&D & D&N, Arunachal Pradesh and Lakshadweep.
The Ministry of Ayush has started free distribution of AYUSH 64 at many locations in Delhi since last Saturday. From Monday onwards, many more centres will become operational. Those COVID-19 patients who are in home isolation or are staying at some government/NGO arranged isolation centres can benefit from this initiative of the Ministry of Ayush.
Patients or their representatives can visit these centres with the hard or soft copies of patient’s RT PCR positive report and Aadhar Card to get a free pack of AYUSH 64 tablets. Replenishment, if and when required, will also be provided free of cost.
It may be noted AYUSH 64 is a poly herbal formulation that has been found useful in the treatment of asymptomatic, mild and moderate COVID-19 infection. AYUSH-64 is recommended in National Clinical Management Protocol based on Ayurveda and Yoga which is vetted by National Task Force on COVID Management of ICMR and Guidelines for Ayurveda Practitioners for COVID-19 Patients in Home Isolation. It has been repurposed as an add on to standard care for COVID-19 patients after a robust multi-centre clinical trial which was monitored by Ministry of AYUSH-CSIR Joint Monitoring Committee for clinical trial under the chairmanship of Dr. V M Katoch, former DG, ICMR.
The seven centres where Ayush 64 will be available to asymptomatic, mild and moderate COVID-19 patients from Monday onwards are All India Institute of Ayurveda(AIIA), Sarita Vihar (9.30 am – 1.00 pm); Morarji Desai National Institute of Yoga, Ashoka Road (all seven days, 8.30 am – 4.30 pm); Regional Research Institute of Unani Medicine, Abul Fazal Enclave Part-1, Jamia Nagar, Okhla (9 am – 5 pm); Unani Medical Centre, Room no. 111-113, Main OPD Building, First Floor, Gate no. 7, Safdarjung Hospital (9 am – 4 pm); Unani Speciality Clinic, Dr. M A Ansari Health Centre, Jamia MIllia Islamia (9 am – 4.30 pm); Central Ayurveda Research Institute, Street no. 66, Punjabi Bagh (9.30 – 4 pm) and Central Council for Research in Yoga and Naturopathy, opp. D-block, Janakpuri (9 am – 12 pm). The Naturopathy Hospital of CCRYN in sector 19 in Rohini will also start distributing free AYUSH 64 from Wednesday (9 am – 12 noon).
Apart from this a sale counter is also set up at the reception of Ayush Bhawan, B- block, GPO complex where both AYUSH 64 and AYURAKSHA kits are available.
Indian Railways is continuing its journey of bringing relief by delivering Liquid Medical Oxygen(LMO) to various states across the country. So far, Indian Railways has delivered nearly 3400 MT of LMO in more than 220 tankers to various states across the country.
54 Oxygen Expresses have already completed their journey so far.
It is Indian Railways endeavour to deliver as much LMO as possible in the shortest time possible to the requesting states.
Till the time of this release, 230 MT has been offloaded in Maharashtra, 968 MT in UP, 249 MT in MP, 355 MT in Haryana, 123 MT in Telangana, 40 MT in Rajasthan and 1427 MT in Delhi.
Presently 26 tankers are on the run with 417 MT of LMO which are expected to arrive in Maharashtra, UP, Haryana and Delhi. Running of new Oxygen is a very dynamic exercise and figures keep getting updated all the time. More loaded Oxygen Expresses are expected to start their journeys later in the night.
An anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG) has been developed by Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRDO), in collaboration with Dr Reddy’s Laboratories (DRL), Hyderabad. Clinical trial results have shown that this molecule helps in faster recovery of hospitalised patients and reduces supplemental oxygen dependence. Higher proportion of patients treated with 2-DG showed RT-PCR negative conversion in COVID patients. The drug will be of immense benefit to the people suffering from COVID-19.
Pursuing Prime Minister Shri Narendra Modi’s call for preparedness against the pandemic, DRDO took the initiative of developing anti-COVID therapeutic application of 2-DG. In April 2020, during the first wave of the pandemic, INMAS-DRDO scientists conducted laboratory experiments with the help of Centre for Cellular and Molecular Biology (CCMB), Hyderabad and found that this molecule works effectively against SARS-CoV-2 virus and inhibits the viral growth. Based on these results, Drugs Controller General of India’s (DCGI) Central Drugs Standard Control Organization (CDSCO) permitted Phase-II clinical trial of 2-DG in COVID-19 patients in May 2020.
The DRDO, along with its industry partner DRL, Hyderabad, started the clinical trials to test the safety and efficacy of the drug in COVID-19 patients. In Phase-II trials (including dose ranging) conducted during May to October 2020, the drug was found to be safe in COVID-19 patients and showed significant improvement in their recovery. Phase IIa was conducted in six hospitals and Phase IIb (dose ranging) clinical trial was conducted at 11 hospitals all over the country. Phase-II trial was conducted on 110 patients.
In efficacy trends, the patients treated with 2-DG showed faster symptomatic cure than Standard of Care (SoC) on various endpoints. A significantly favourable trend (2.5 days difference) was seen in terms of the median time to achieving normalisation of specific vital signs parameters when compared to SoC.
Based on successful results, DCGI further permitted the Phase-III clinical trials in November 2020. The Phase-III clinical trial was conducted on 220 patients between December 2020 to March 2021 at 27 COVID hospitals in Delhi, Uttar Pradesh, West Bengal, Gujarat, Rajasthan, Maharashtra, Andhra Pradesh, Telangana, Karnataka and Tamil Nadu. The detailed data of phase-III clinical trial was presented to DCGI. In 2-DG arm, significantly higher proportion of patients improved symptomatically and became free from supplemental oxygen dependence (42% vs 31%) by Day-3 in comparison to SoC, indicating an early relief from Oxygen therapy/dependence.
The similar trend was observed in patients aged more than 65 years. On May 01, 2021, DCGI granted permission for Emergency Use of this drug as adjunct therapy in moderate to severe COVID-19 patients. Being a generic molecule and analogue of glucose, it can be easily produced and made available in plenty in the country. The drug comes in powder form in sachet, which is taken orally by dissolving it in water. It accumulates in the virus infected cells and prevents virus growth by stopping viral synthesis and energy production. Its selective accumulation in virally infected cells makes this drug unique.
In the ongoing second COVID-19 wave, a large number of patients are facing severe oxygen dependency and need hospitalisation. The drug is expected to save precious lives due to the mechanism of operation of the drug in infected cells. This also reduces the hospital stay of COVID-19 patients.
Dr. Harsh Vardhan, Union Minister of Health and Family Welfare today reviewed in person the preparedness of Dr Ram Manohar Lohia Hospital, New Delhi for clinical management of the severe COVID19 patients. He has been personally reviewing the management of COVID19 in the Central Hospitals that serve Delhi and had also visited the Lady Hardinge Medical College recently.
In view of the unprecedented surge in daily COVID19 cases, uninterrupted requirement of oxygen, oxygen supported and ICU beds in addition to adequate supply of medicines and trained manpower has increased manifold in the Capital. The Government of India in line with its pro-active and graded approach has continuously reviewed the emerging situation in Delhi. The Union Government continues to lead the fight against the COVID19 pandemic in collaboration with the States and UT through a “Whole of Government” approach.
At the outset, the Union Health Minister visited the vaccination centre inside the hospital and interacted with the beneficiaries getting vaccinated and those being monitored for AEFI post vaccination. They all assured him that the entire process was smooth. Persons being monitored for AEFI informed that they did not feel any difficulty after their vaccination.
Dr. Harsh Vardhan said, “Everybody should take the second dose of vaccination for full protection and follow COVID Appropriate Behaviour and necessary precautions even after their second dose.” Through the media, he also appealed to the States to keep 70% of vaccines they receive under ‘GoI’ channel for the second dose.
There has been an unprecedented surge in the number of COVID19 cases in the country since the past few weeks. The health infrastructure of several States and UTs has been overwhelmed by the very high number of daily cases and increased mortality.
Following the spirit of Vasudhaiva Kutumbakam, the global community has extended a helping hand in supporting efforts of Government of India in this collective fight against the global COVID19 pandemic.
Government of India has been receiving international donations/aid of Covid-19 relief medical supplies and equipment since 27 April 2021 from different countries. All items received so far are allocated to the states/institutions and substantial part of it stands delivered. This is an ongoing exercise. The aim is to extend all support and assistance through various means and measures to strengthen the States’ and UT’s efforts during this critical phase.
On the other hand, the cumulative number of COVID19 vaccine doses administered in the country has crossed 16.25 Cr today as the Phase-3 of the nationwide Vaccination Drive expands further.
9,04,263 beneficiaries of the age group 18-44 years received their first dose of COVID vaccine across 12 States. These states are Chhattisgarh (1,026), Delhi (1,29,096), Gujarat (1,96,860), Jammu and Kashmir (16,387), Haryana (1,23,484), Karnataka (5,328), Maharashtra (1,53,966), Odisha (21,031), Punjab (1,535), Rajasthan (1,80,242), Tamil Nadu (6,415) and UP (68,893).
Cumulatively, 16,25,13,339 vaccine doses have been administered through 29,34,844 sessions, as per the provisional report till 7 am today. These include 94,80,739 HCWs who have taken the 1st dose and 63,54,113 HCWs who have taken the 2nd dose, 1,36,57,922 FLWs (1stdose), 74,25,592 FLWs (2nddose), 9,04,263 beneficiaries under 18-45 age group (1st dose), 5,31,16,901 1st dose beneficiaries and 1,29,15,354 2nd dose beneficiaries more than 60 years old and 5,38,15,026 (1st dose) and 48,43,429 (2nd dose) beneficiaries aged 45 to 60 years.
Union Minister of State (Independent Charge) Development of North Eastern Region (DoNER), MoS PMO, Personnel, Public Grievances, Pensions, Atomic Energy and Space, Dr Jitendra Singh today said that Department of Space has gone beyond its call to provide COVID related support mainly liquid oxygen to States of Tamil Nadu, Kerala, Andhra Pradesh and Chandigarh. In an online review meeting, Chairman, ISRO, Dr. K. Sivan said that 9.5 tonnes of oxygen being given to Tamil Nadu and Kerala per day, besides the oxygen capacity of Andhra Pradesh and Chandigarh was augmented. He said, 87 tonnes of LOX manufactured and supplied by ISRO Propulsion Complex, IPRC already given to Tamil Nadu and Kerala by ensuring 24×7 work schedule. Moreover, 12 MT of LOX sent to augment Oxygen availability in Andhra Pradesh. He said, the Department is also ensuring supply of Oxygen cylinders for local public in Andhra Pradesh and Kerala. Advanced Medical devices designed including ventilators, Prana, and VaU and manufacturing to be taken up with industries at the earliest.
Dr Jitendra Singh was informed that the Space Application Centre at Ahmedabad has successfully converted 2 Liquid Nitrogen Tanks of about 1.65 lakh litres into liquid oxygen tanks for storage and supply in Ahmedabad and nearby hospitals. Moreover, Face Shields and PPE kits are also being supplied to hospitals in Ahmedabad.
The Minister said that Oxygen Concentrators being procured for Dispensaries for use by needy patients and the Design of disinfectant chamber for baggage & new Oxygen concentrators is already in progress.
The other technological support provided by the Department of Space includes, Covid vaccination centers mapping across India integrated with Cowin app to help citizen reach the nearest vaccination center, deployment of Non-contact Thermal camera developed by SAC, development of COVID-19 Dashboard in Sync with Ministry of Health and Family Welfare and the development of a mobile app ‘FIGHT CORONA’ in collaboration with ICMR, Dibrugarh, Assam for collection of geotagged information of Covid19 cases in the state of Tripura.
Senior officials of Department of Space informed Dr Jitendra Singh that work is on for the 10 scheduled Satellite launch projects including the unmanned Gaganyaan Mission in December this year. The Minister expressed satisfaction that despite the crippling effects of the pandemic, the launch campaign activities continued over Virtual Launch Control for PSLV-C49, C50 and C51 during the past six months.
Dr Jitendra Singh also asked the department to explore the possibility of creating more COVID Care Centres apart from the ones established in Bengaluru, Shillong and Sriharikota.
The Minister expressed satisfaction over the various measures taken the Department of Space to contain the COVID menace and specially appreciated the introduction of Bio-bubble teams and vaccination of about 30 percent of the staff so far.
The Cabinet Committee on Economic Affairs, chaired by Prime Minister, Narendra Modi, has given its in-principle approval for strategic disinvestment along with transfer of management control in IDBI Bank Ltd. The extent of respective shareholding to be divested by GoI and LIC shall be decided at the time of structuring of transaction in consultation with RBI.
Government of India (GoI) and LIC together own more than 94% of equity of IDBI Bank (GoI 45.48%, LIC 49.24%). LIC is currently the promoter of IDBI Bank with Management Control and GoI is the co-promoter.
LIC’s Board has passed a resolution to the effect that LIC may reduce its shareholding in IDBI Bank Ltd. through divesting its stake along with strategic stake sale envisaged by the Govt. with an intent to relinquish management control and by taking into consideration price, market outlook, statutory stipulation and interest of policy holders.
This decision of LICs Board is also consistent with the regulatory mandate to it to reduce its stake in the Bank.
It is expected that strategic buyer will infuse funds, new technology and best management practices for optimal development of business potential and growth of IDBI Bank Ltd. and shall generate more business without any dependence on LIC and Government assistance/funds. Resources through strategic disinvestment of Govt. equity from the transaction would be used to finance developmental programmes of the Government benefiting the citizens.
In order to tackle the surge in Covid-19 cases & subsequent requirement of oxygen, PM-Cares has allocated funds for the installation of 500 Medical Oxygen Plants across the country. These plants are planned to be set up within three months. Defence Research and Development Organisation (DRDO), through its industries, is setting-up five Medical Oxygen Plants within the first week of May in and around Delhi. These are to be installed at AIIMS Trauma Centre, Dr Ram Manohar Lohia Hospital (RML), Safdarjung Hospital, Lady Hardinge Medical College and one at AIIMS, Jhajjar, Haryana. As per schedule, two of these plants reached Delhi on May 4, 2021 and are being installed at AIIMS and RML Hospitals respectively.These have been supplied by M/s Trident Pneumatics Pvt. Ltd., Coimbatore which is the technology partner of DRDO and has been given an order of 48 plants. Order of 332 plants have been placed with M/s Tata Advanced Systems Limited and the delivery will start from mid–May. The delivery schedule is being monitored very closely to deliver before the plants time. Sites are being prepared at each hospital in parallel.
These Medical Oxygen Plants are designed for a flow rate of 1,000 litres per minute (LPM). The system can cater to 190 patients at a flow rate of 5 LPM and charge 195 cylinders per day. The Medical Oxygen Plant (MOP) technology has been developed by DRDO based on the On‐Board Oxygen Generation for LCA, Tejas. These plants will overcome the logistics issues of oxygen transportation and help the COVID-19 patients in emergency. CSIR has also ordered 120 MOP plants through its industries.